Helus Pharma Inc. Common Stock
HELP
70 hedge funds and large institutions have $12.4M invested in Helus Pharma Inc. Common Stock in 2023 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 10 increasing their positions, 5 reducing their positions, and 9 closing their positions.
698% more capital invested
Capital invested by funds: $1.56M → $12.4M (+$10.9M)
111% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 9
100% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 5
15% more funds holding
Funds holding: 61 → 70 (+9)
7.82% more ownership
Funds ownership: 2.16% → 9.98% (+7.8%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
+$7.34M |
| 2 |
Jane Street
New York
|
+$145K |
| 3 |
VF
Virtu Financial
New York
|
+$52.5K |
| 4 |
CWM
Connecticut Wealth Management
Farmington,
Connecticut
|
+$20.9K |
| 5 |
TWM
Thrive Wealth Management
Audubon,
Pennsylvania
|
+$20.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AI
AdvisorShares Investments
Bethesda,
Maryland
|
-$82.2K |
| 2 |
FIA
FNY Investment Advisers
New York
|
-$53.5K |
| 3 |
ICG
InterOcean Capital Group
Nashville,
Tennessee
|
-$37.8K |
| 4 |
Barclays
London,
United Kingdom
|
-$22.8K |
| 5 |
Cerity Partners
New York
|
-$21.1K |
HELP Hedge Fund Activity: Q3 2023 in Review
70 of the 6,313 institutional investors tracked by Wall St. Rank reported a position in Helus Pharma Inc. Common Stock (HELP) for Q3 2023, worth a combined $12.4M — up 698% from $1.56M a quarter earlier.
Buyers outnumbered sellers: 19 funds opened new HELP positions and 9 closed out — a net gain of 10 holders — while 10 added to existing stakes and 5 trimmed.
The largest buyer was Point72 Asset Management, opening a new position worth an estimated $7.34M. The largest seller was AdvisorShares Investments, cutting an estimated $82.2K.
- 70 institutional investors held Helus Pharma Inc. Common Stock (HELP) as of Q3 2023, up from 61 in Q2 2023.
- Funds reported $12.4M of Helus Pharma Inc. Common Stock stock for Q3 2023, up 698% quarter-over-quarter.
- 19 funds opened new Helus Pharma Inc. Common Stock positions in Q3 2023 and 9 closed out, a net change of +10 holders.
- The largest Helus Pharma Inc. Common Stock buyer in Q3 2023 was Point72 Asset Management, an estimated $7.34M added.
- The largest Helus Pharma Inc. Common Stock seller in Q3 2023 was AdvisorShares Investments, an estimated $82.2K sold.
Based on aggregated 13F filings for Q3 2023.